Delivery Order SPE2DR25D3103-SPE2DR26F9M98
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,095.49 to AmerisourceBergen Drug Corp for Ozempic 0.25-0.5 mg/dose pens (3ml) on May 13, 2025, with an ultimate completion date of May 14, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and performs at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $2,523.08 to AmerisourceBergen Drug Corp for Ozempic 0.25-0.5 mg/dose pens (3ml) on December 3, 2025, with an ultimate completion date of December 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $13,310.20 delivery order to AmerisourceBergen Drug Corp for Ozempic 0.25-0.5 mg/dose pens (3 mL) on December 2, 2025, with completion scheduled for December 3, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $3,704.22 delivery order to AmerisourceBergen Drug Corp for Ozempic 0.25-0.5 mg/dose pens (3 mL) on October 23, 2025, with completion targeted for October 24, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $3,759.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ozempic 0.25-0.5 mg/dose pens (3ml) on August 25, 2025, with an ultimate completion date of August 26, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $5,574.45 delivery order to AmerisourceBergen Drug Corp for Ozempic 0.25-0.5 mg/dose pens (3mL) on September 2, 2025, with an ultimate completion date of September 3, 2025. This is a firm fixed-price, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $13,541.70 delivery order to AmerisourceBergen Drug Corp for Ozempic (0.25-0.5 mg/dose pen, 3ml) on July 30, 2025, with a completion date of July 31, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $2,661.03 to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3mL). This is a firm fixed price delivery order with an ultimate completion date of August 4, 2025. The contract carries no set-aside designation, indicating it was awarded through open competition. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $10,493.06 delivery order to AmerisourceBergen Drug Corp for Ozempic 0.25-0.5 mg/dose pens (3ml) with an ultimate completion date of August 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award to the pharmaceutical distributor. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $3,779.08 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL) on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and specifies Conshohocken, Pennsylvania as the place of performance. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9M98Delivery Order
The Defense Logistics Agency awarded a $10,422.94 delivery order to AmerisourceBergen Drug Corp for Ozempic 0.25-0.5 mg/dose pens (3 mL) on December 9, 2025, with an ultimate completion date of December 10, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is performance-based in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 prime vendor agreement running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, supplies a broad portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support Department of Defense and veteran healthcare systems. The company's extensive federal contract history with DLA demonstrates its capability to meet competitive procurement requirements across multiple therapeutic domains. This particular delivery order for Ozempic, a diabetes medication commonly used within military medical supply chains, reflects the company's role in fulfilling pharmaceutical needs for authorized federal health programs and beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.4k | 12/8/25 |